Evaluation of the tumor blood flow by computed tomography(CT)perfusion imaging and an effect of chemotherapy or radiotherapy for esophageal cancer

Evaluation of the tumor blood flow by computed tomography(CT)perfusion imaging and an effect of chemotherapy or radiotherapy for esophageal cancer - Tumor blood flow by CT perfusion imaging and effect of treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015597

Enrollment

Registered

2014-11-04

Start date

2014-10-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

If the patients who will undergo chemotherapy or radiotherapy, they have to be taken CT Perfusion imaging twice (before and after therapy) Scan protocol : 80kV,60-100mA, 0.5sec/rot, 0.5mm*320(scan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Untreated esophageal cancer, tumor depth is T1 or more. (TNM UICC ver7) Patients who can be undergone CT perfusion imaging Written informed concent by themselves

Exclusion criteria

Exclusion criteria: Patients who has been treated for esophageal cancer before Patienst who is unable to take CT Perfusion imaging by severe renal failure and iodine allergy Pregnant and lactating woman

Design outcomes

Primary

Measure	Time frame
Correlation between tumor blood flow before chemotherapy or radiotherapy and clinical effect of these therapy. Evaluate to change of tumor blood flow before and after the therapies.	—

Secondary

Measure	Time frame
Correlation between tumor blood flow and short-term prognosis	—

Countries

Japan

Contacts

Public ContactYu Onodera

Tohoku University Graduate School of Medicine Division of Advanced Surgical Science and Technology

yu_con_gray@hotmail.com022-717-7214

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026